Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: Results from a pilot randomized controlled study.
Yu-Hsiang HsiehAndrea F DugasFrank LoVecchioBreana McBrydeErin P RickettsKathryn Saliba-ShawRichard E RothmanPublished in: Influenza and other respiratory viruses (2020)
Clinical outcomes of influenza-infected patients treated with single-dose IV peramivir were comparable to those treated with oral oseltamivir, suggesting potential utility of peramivir for influenza-infected patients in the ED.